Related Experiment Videos
Risk factors for late kidney allograft failure
Claudio Ponticelli1, Margarita Villa, Bruno Cesana
1Divisione di Nefrologia e Dialisi, and Epidemiologic Unit, IRCCS Ospedale Maggiore Milano, Milano, Italy.
Kidney International
|October 10, 2002
Summary
Long-term kidney transplant survival is limited by chronic allograft nephropathy and death. Managing cardiovascular risk factors and optimizing patient selection are key to improving graft survival and patient life expectancy.
Area of Science:
- Nephrology
- Transplantation Immunology
- Cardiovascular Medicine
Background:
- Short-term renal allograft survival has improved, but long-term graft survival remains a challenge.
- Cyclosporine A (CsA) is a common immunosuppressant, and understanding its impact on long-term outcomes is crucial.
Purpose of the Study:
- To evaluate the causes of late graft failure in renal allograft recipients treated with CsA.
- To identify factors associated with graft failure and patient death.
Main Methods:
- A cohort of 864 adult renal allograft recipients with functioning grafts at one year was analyzed.
- End points included return to dialysis or death with a functioning graft.
Main Results:
- The 13-year graft survival probability was 0.64, with a graft half-life of 20.1 years.
- Chronic allograft nephropathy was the leading cause of late failure (97 patients), followed by death (70 patients).
- Factors associated with graft failure included higher creatinine and LDL levels at one year, older age, and delayed graft function. Cardiovascular complications were the most frequent cause of death, associated with pre-transplant cardiovascular events, older age, hypertension, smoking, and dialysis duration.
Conclusions:
- Chronic allograft nephropathy and death are the primary drivers of late renal allograft loss.
- Optimizing pre-transplant patient selection, preparation, and lifestyle modifications are recommended to enhance long-term graft survival and overall life expectancy.